CIK 0001022899 · Non-accelerated filer<br>Smaller reporting company
Protagenic Therapeutics, Inc.new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061390025
- Phone
- (212) 994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- Open-market buys, last 90 days
- $23,756
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,756. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-12-10 | MUSCI RAYMOND Exec VP, Corporate Development | Purchase | +100 | $1.70 | $170 | 110,255 |
| 2010-12-10 | MUSCI RAYMOND Exec VP, Corporate Development | Purchase | +3,499 | $1.79 | $6K | 113,754 |
| 2010-12-10 | MUSCI RAYMOND Exec VP, Corporate Development | Purchase | +5,000 | $1.90 | $10K | 118,754 |
| 2010-12-10 | MUSCI RAYMOND Exec VP, Corporate Development | Purchase | +200 | $1.59 | $318 | 436,021 |
| 2010-12-10 | MUSCI RAYMOND Exec VP, Corporate Development | Purchase | +300 | $1.60 | $480 | 436,321 |
| 2010-12-10 | MUSCI RAYMOND Exec VP, Corporate Development | Purchase | +600 | $1.63 | $978 | 436,921 |
| 2010-12-10 | MUSCI RAYMOND Exec VP, Corporate Development | Purchase | +100 | $1.64 | $164 | 437,021 |
| 2010-12-10 | MUSCI RAYMOND Exec VP, Corporate Development | Purchase | +100 | $1.70 | $170 | 437,121 |
| 2010-12-10 | MUSCI RAYMOND Exec VP, Corporate Development | Purchase | +3,499 | $1.79 | $6K | 440,620 |
| 2010-12-10 | MUSCI RAYMOND Exec VP, Corporate Development | Purchase | +5,000 | $1.90 | $10K | 445,620 |
| 2010-09-28 | ELLIN ROBERT S Director | Grant or award · Restricted Stock Units | +37,610 | 37,610 | ||
| 2010-09-28 | DYNE MARK Director | Grant or award · Restricted Stock Units | +37,610 | 37,610 | ||
| 2010-09-28 | CHAZEN JEROME A Director | Grant or award · Restricted Stock Units | +64,159 | 64,159 | ||
| 2010-09-28 | BURSTEIN LAWRENCE Director | Grant or award · Restricted Stock Units | +37,610 | 37,610 | ||
| 2010-06-30 | Plotts Thomas Chief Financial Officer | Grant or award · Options to Purchase Common Stock | +250,000 | 250,000 | ||
| 2010-06-03 | DYNE MARK Director | Other disposition | −20,000 | 746,369 | ||
| 2010-03-31 | Plotts Thomas Interim CFO | Option exercise | +25,000 | 38,337 | ||
| 2010-03-31 | Plotts Thomas Interim CFO | Shares withheld for taxes | −9,718 | $0.82 | $8K | 28,619 |
| 2010-03-31 | Plotts Thomas Interim CFO | Option exercise · Restricted Stock Units | −25,000 | 0 | ||
| 2010-01-29 | Plotts Thomas Interim CFO | Grant or award · Restricted Stock Units | +25,000 | 25,000 |
Page 5 of 10 · 196 trades